This inventor holds 12 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Sinew Pharma Inc., Avalon Hepapoc Limited, National Defense Education and Research Foundation. Active years: 2000-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taipei 100, TW (2000)
- Taipei, TW (2001 - 2024)
Company Filing History:
4 out of 4 
1 out of 1 
1 out of 4 Years Active: 2000-2024
Title: Oliver Yoa-Pu Hu: Innovator in Hepatotoxicity Treatments
Introduction
Oliver Yoa-Pu Hu, based in Taipei, Taiwan, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of 12 patents, his work particularly focuses on innovative compounds aimed at treating hepatotoxicity and fatty liver diseases.
Latest Patents
Among his latest patents, Hu has developed "Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases." These compounds are structured in a complex formula, where each X signifies a carbonyl group, and R includes both C-Calkyl polyol and saccharide components. This innovation holds promise for effectively addressing hepatotoxicity and fatty liver conditions.
Another noteworthy patent from Hu is the "Hepatotoxicity-free pharmaceutical composition containing acetaminophen drugs." This groundbreaking composition is designed to alleviate the liver toxicity associated with acetaminophen. It incorporates a pharma-effective amount of acetaminophen, combined with safe excipients that reduce toxicity through liver enzyme metabolism, specifically targeting the CYP2E1 pathway.
Career Highlights
Throughout his career, Oliver Yoa-Pu Hu has collaborated with various organizations, leaving a significant impact in the pharmaceutical sector. He has worked at prominent companies, including Sinew Pharma Inc., which highlights his commitment to advancing pharmaceutical innovation.
Collaborations
Hu's collaborative efforts have involved notable colleagues such as Cheng-Huei Hsiong and Tung-Yuan Shih. These partnerships have likely enhanced his research and development capabilities, leading to a more profound understanding of liver-related pharmacology.
Conclusion
With a clear focus on developing innovative treatments for liver diseases, Oliver Yoa-Pu Hu stands out as a prominent inventor in pharmaceutical science. His patents not only reflect his ingenuity but also his dedication to improving patient outcomes related to hepatotoxicity and liver health. As he continues his work, the impact of his inventions will likely be felt across the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile